The stock prices of China’s big internet companies fell Friday after the country’s legislative body adopted a new, strict privacy law to come into force on November 1.
Alibaba shares were down 2.6%, with Tencent Music falling 3% before recovering later in the day. Hong Kong’s Hang Seng Index fell 1.8% and the CSI 300 composite of Chinese blue chips dropped 2%.
A report by the official Xinhua News Agency said that the law was voted by the National People’s Congress and promulgated immediately by president Xi Jinping.
Its passage marks another step in the Chinese government and regulators’ crackdown on the country’s biggest internet companies, tightening the regulation of cyberspace and strengthening compliance requirements, to better protect user privacy.
Chinese authorities in early July announced a cybersecurity probe of Didi, the ride-hailing app, just three days after the company started listing on the New York Stock Exchange. The stock price is down 49% since then.
Top Blue Chip Stocks To Own For 2023: Oil States International Inc.(OIS)
Oil States International, Inc., through its subsidiaries, provides specialty products and services to the oil and gas drilling and production companies worldwide. It operates in four segments: Accommodations, Offshore Products, Well Site Services, and Tubular Services. The Accommodations segment offers temporary and permanent work force accommodation services for people working in remote locations. The Offshore Products segment designs and manufactures flexible bearings and connector products; sub sea pipeline products; marine winches, mooring systems, and cranes and rig equipment; and conductor casing connections and pipes, as well as provides blowout preventer stack assembly, integration, testing, and repair services; and drilling riser and related repair services. The Well Site Services segment offers a range of products and services that are used to drill for, and establish and maintain the flow of oil and gas from a well throughout its lifecycle. This segment engages in the rental of wireline and coiled tubing pressure control equipment; wellhead isolation equipment; pipe recovery systems; thru-tubing fishing services; hydraulic chokes and manifolds; blow out preventers; well testing and flowback equipment; gravel pack operations on well bores; and surface control equipment and down-hole tools utilized by coiled tubing operators. This segment also provides land drilling services. The Tubular Services segment distributes a range of casing and tubing products; and offers threading, logistical, and inventory management services. The company serves national oil companies, independent oil and gas companies, onshore and offshore drilling companies, and other oilfield service and mining companies. Oil States International, Inc. was founded in 1995 and is based in Houston, Texas.
- [By Motley Fool Transcribers]
Oil States International Inc (NYSE:OIS)Q4 2018 Earnings Conference CallFeb. 14, 2019, 11:00 a.m. ET
Prepared Remarks Questions and Answers Call Participants
- [By Shane Hupp]
Shares of Oil States International, Inc. (NYSE:OIS) have received an average recommendation of “Hold” from the nineteen brokerages that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, thirteen have issued a hold rating and four have assigned a buy rating to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $32.38.
- [By Logan Wallace]
Equities researchers at Morgan Stanley began coverage on shares of Oil States International (NYSE:OIS) in a research note issued on Tuesday, The Fly reports. The brokerage set a “hold” rating and a $35.00 price target on the oil and gas company’s stock. Morgan Stanley’s price objective indicates a potential upside of 13.45% from the company’s current price.
Top Blue Chip Stocks To Own For 2023: U.S. Energy Corp.(USEG)
U.S. Energy Corp. (“U.S. Energy”, the “Company”, “we” or “us”), is a Wyoming corporation organized in 1966. We are an independent energy company focused on the acquisition and development of oil and gas producing properties in the continental United States. Our business activities are currently focused in South Texas and the Williston Basin in North Dakota. However, we do not intend to limit our focus to these geographic areas. We continue to focus on increasing production, reserves, revenues and cash flow from operations while managing our level of debt.
We have historically explored for and produced oil and gas through a non-operator business model. As a non-operator, we rely on our operating partners to propose, permit, drill, complete and produce oil and gas wells. Advisors’ Opinion:
- [By Shane Hupp]
News headlines about U.S. Energy (NASDAQ:USEG) have trended somewhat positive this week, Accern Sentiment Analysis reports. The research group scores the sentiment of news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. U.S. Energy earned a daily sentiment score of 0.12 on Accern’s scale. Accern also assigned press coverage about the energy company an impact score of 46.1711250941963 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
- [By Ethan Ryder]
News stories about U.S. Energy (NASDAQ:USEG) have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm ranks the sentiment of press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. U.S. Energy earned a media sentiment score of 0.12 on Accern’s scale. Accern also assigned headlines about the energy company an impact score of 46.6605255497675 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
Top Blue Chip Stocks To Own For 2023: Nestlé S.A. (NSRGF)
Nestle S.A. is a nutrition, health and wellness company. The Company’s segments are Zone Europe, Middle East and North Africa (EMENA); Zone Americas (AMS); Zone Asia, Oceania and sub-Saharan Africa (AOA); Nestle Waters; Nestle Nutrition, and Other Businesses. The Company’s product categories include powered and liquid beverages; water; milk products and ice cream; nutrition and health science; confectionery, and PetCare. The Company’s other business activities include the operations of Nestle Professional, Nespresso, Nestle Health Science and Nestle Skin Health. It operates in approximately 190 countries around the world. The Company has sales in various countries, including the United States, Greater China Region, Brazil, Germany, the United Kingdom, Mexico, Philippines, Italy, Canada, France, Spain and Switzerland, among others. The Company offers over 2,000 brands of products around the world. Advisors’ Opinion:
- [By ]
A year ago July, I recommended ASBFY a BUY along with Nestlé (OTCPK: NSRGY) (OTCPK: NSRGF). Briefly, ASBFY is
A diversified international food, ingredients and retail group with sales of more than $32.6B operating in 50 countries on six continents Owner of brands including Mazola, Karo Syrup, Fleischmann Yeast, Durkee, Twinings Ovaltine, Tip Top Bakeries and more A huge producer of sugar and bioethanol fuels from China to Spain, and Africa’s largest sugar producer with factories in six countries A supplier of products and tech services to farmers, feed and food manufacturers, processors and retailers A producer of yeast and bakery ingredients operating plants in 32 countries and selling into 92 countries, plus it manufactures and markets enzymes, lipids, yeast extracts, and cereal specialties Primark is the ASBFY signature fashion chain with more than 300 stores in the UK and across Europe that bolsters ASBFY by accounting for half the company’s revenue and profit. Share Price Slump Is An Opportunity
Shares last July were selling in the $39 range, rose to $45 close to November 2017, then began a slow but steady slide downhill opening August ’18 at just above $31. July 5, ’18 ASBFY announced “group revenue from continuing businesses for the 40 weeks ended 23 June 2018 was 3% ahead of the same period last year at constant currency and 2% ahead at actual exchange rates. Excluding Sugar, sales growth the developed from continuing businesses was 6% ahead of last year at constant currency and 5% ahead at actual exchange rates.” The grocery business pushed ahead 4% in the quarter with margins expected to increase for the full year. Ingredients revenue was up 4% and revenue from agriculture in the third quarter was +12% ahead of last year. Sales at Primark were +6% as sales space expanded.
Top Blue Chip Stocks To Own For 2023: Takeda Pharmaceutical Company L(TAK)
Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, marketing, and out-licensing of pharmaceutical products worldwide. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such as rare metabolic and hematology, and heredity angioedema, as well as plasma-derived therapies and vaccines. The company provides its products under the Entyvio, Gattex/Revestive, Alofisel, Natpara, Adynovate/Adynovi, Takhzyro, Elaprase, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Albumin/Flexbumin, Ninlaro, and Alunbrig brands. Takeda Pharmaceutical Company has licensing agreements with Denali Therapeutics and Wave Life Sciences Ltd; collaboration agreements with Neurocrine Biosciences, Inc. and Rani Therapeutics LLC; license and research agreements with The University of Texas MD Anderson Cancer Center and Arrowhead Pharmaceuticals Inc.; research collaboration agreements with Arrowhead Pharmaceuticals Inc. and Ovid Therapeutics Inc.; and collaboration with Evox Therapeutics Ltd., as well as a licensing agreement with ProThera Biologics Inc. It also has strategic alliances with Egle Therapeutics SAS; Evotec SE; Neurocrine Biosciences, Inc.; Carmine Therapeutics; HemoShear Therapeutics, LLC; KSQ Therapeutics; and Anima Biotech. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.
- [By Josh Enomoto]
However, Bayer’s overlooked nature brings opportunity for contrarians. Gurufocus.com labels Bayer modestly undervalued. To be fair, the company’s three-year revenue growth rate stands just above middle of the road. However, Bayer features no debt, giving it incredible flexibility. As well, it commands an operating margin of 21.7%, ranked better than 87.5% of competing pharmas.
Takeda Pharmaceutical (TAK) Source: Sisacorn / Shutterstock.com
Representing one of the largest pharmaceutical companies in the world by revenue, Takeda Pharmaceutical (NYSE:TAK) focuses on several advanced therapeutics. As it states on its website:
- [By Thomas Niel]
Most recently, this was seen with the company’s deal with Takeda Pharmaceutical (NYSE:TAK) in Japan. As InvestorPlace’s Samuel O’Brient reported on Sept. 7, the company is licensing its vaccine to Takeda, which will manufacture 150 million doses for the Japanese government. This deal is particularly promising in two ways.
- [By Joe Tenebruso (tmfguardian)]
Takeda Pharmaceutical (NYSE:TAK) will license Novavax’s formula and technology, and manufacture the vaccine in Japan. The healthcare giant plans to begin distributing the drug early next year.